Mental Health, Physicals, Specialization and Webinar

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law Blog

FEBRUARY 27, 2023

While no “special registration” will yet be required to engage in telemedicine prescribing of controlled substances, DEA is proposing parameters to guide the practice of telemedicine encounters in a post-COVID world. We will release exciting details of our upcoming webinar addressing telemedicine soon. 21 U.S.C. § 802(54)(D)(i).

Telemedicine

Telemedicine Telecommunication Telehealth Medical

Agitation Podcast Series Episode 2: Non-pharmacologic management of agitated children

PEMBlog

MAY 24, 2023

This entails utilizing the least invasive non-pharmacologic means of assisting them, before moving to physical or chemical restraints. Special thanks to Manpreet Singh, MD ( @MprizzleER ) for helping to put this collaboration together. Deaths due to physical restraint. Physical and chemical restraints. Dtsch Arztebl Int.

Management

Management Patient-Centered Physicals Finance

Primary Care Digest

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

Agitation Podcast Series Episode 2: Non-pharmacologic management of agitated children

Stay Connected